Calcium Gluconate has become the latest addition to Glenmark Pharmaceuticals' U.S. injectable portfolio, this move supports its strategy to build a differentiated, sustainable U.S. injectables business focused on institutional demand
Mankind Pharma has signed an in-licensing deal with China’s Chongqing Chenan Biopharmaceutical to commercialise two insulin analogues in India and strengthen its diabetes portfolio.
Ophthalmology is becoming a stronger specialty-care focus for Lupin as the company expands its European eye-care business through VISUfarma
Glenmark’s latest USFDA approval covers Fluticasone Propionate Nasal Spray. The FDA has determined the product to be bioequivalent and therapeutically equivalent to Flonase Nasal Spray
India’s heart-lung machine market is set for a major shift as a homegrown device gains key regulatory approvals. The heart-lung machine developed by Mediyant Technologies has received USFDA 510(k) clearance and CDSCO approval.
Indian skincare is entering a new growth phase as established consumer companies move deeper into premium and science-backed beauty
Hearzap today announced the successful completion of its acquisition of Amplifon India's hearing healthcare business. The acquisition took place after definitive agreement announced in May 2026, marking one of the most significant developments...
The GLP-1 boom is pushing companies across consumer industries to rethink what people eat, drink, and buy. Weight-loss drugs are creating new demand beyond the pharmaceutical sector. Companies now see opportunities in nutrition, food, beverages...
Pharmaceutical growth in India is entering a phase where CDMOs can play a larger role in shaping manufacturing, innovation, and global market access
India’s pharmaceutical sector opened FY27 with mixed but largely positive results across exports, domestic sales, and global markets. Pharma exports rose 6.8 percent year over year to USD 8.1 billion in Q1 FY27. Several drugmakers also...
, CDSCO.jpg)